Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Interleukin-2”

431 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 431 results

Large-scale testing (Phase 3)UnknownNCT00149162
What this trial is testing

Treating Patients With Childhood Acute Myeloid Leukemia With Interleukin-2

Who this might be right for
Leukemia
Assistance Publique - Hôpitaux de Paris 580
Testing effectiveness (Phase 2)Study completedNCT00002637
What this trial is testing

Biological Therapy in Treating Patients With Prostate Cancer

Who this might be right for
Prostate Cancer
Memorial Sloan Kettering Cancer Center 25
Testing effectiveness (Phase 2)Study completedNCT00001566
What this trial is testing

A Pilot Study of Autologous T-Cell Transplantation With Vaccine Driven Expansion of Anti-Tumor Effectors After Cytoreductive Therapy in Metastatic Pediatric Sarcomas

Who this might be right for
Ewing's SarcomaRhabdomyosarcoma
National Cancer Institute (NCI) 42
Early research (Phase 1)Not Yet RecruitingNCT07183852
What this trial is testing

Locoregional or Systemic Administration of Autologous Tumor Infiltrating Lymphocytes in Patients With Metastatic Melanoma

Who this might be right for
Metastatic Uveal MelanomaMetastatic Cutaneous Melanoma
Vastra Gotaland Region 18
Early research (Phase 1)Study completedNCT04862767
What this trial is testing

TASO-001 in Combination With Recombinant Interleukin-2(Aldesleukin) in Advanced or Metastatic Solid Tumor

Who this might be right for
Solid Tumor
Autotelicbio 9
Testing effectiveness (Phase 2)Study completedNCT00001475
What this trial is testing

Home Treatment of HIV-Infected Patients With Interleukin-2 With or Without a Tumor Necrosis Factor Antagonist

Who this might be right for
Acquired Immunodeficiency SyndromeHIV Infection
National Institute of Allergy and Infectious Diseases (NIAID) 85
Testing effectiveness (Phase 2)Study completedNCT03415672
What this trial is testing

Hepatitis B Vaccine for Non-responders

Who this might be right for
Hepatitis B
Maastricht University Medical Center 133
Testing effectiveness (Phase 2)Study completedNCT00002681
What this trial is testing

Monoclonal Antibody Plus Interleukin-2 in Treating Patients With Leukemia or Lymphoma

Who this might be right for
LeukemiaLymphoma
Roger Williams Medical Center 25
Not applicableUnknownNCT05569096
What this trial is testing

Tregs CD25 CXCL9 in Vitiligo

Who this might be right for
VitiligoCD25 DeficiencyChemokine (C-X-C Motif)+1 more
Assiut University 40
Large-scale testing (Phase 3)Study completedNCT00053807
What this trial is testing

Interleukin-2, Interferon Alfa, and Fluorouracil Compared With Observation in Treating Patients Who Have Undergone Surgery for Kidney Cancer

Who this might be right for
Kidney Cancer
European Organisation for Research and Treatment of Cancer - EORTC 96
Testing effectiveness (Phase 2)Looking for participantsNCT04263831
What this trial is testing

Low Dose IL-2 for the Treatment of Crohn's Disease

Who this might be right for
Crohn Disease
Boston Children's Hospital 30
Testing effectiveness (Phase 2)Study completedNCT00019448
What this trial is testing

Vaccine Therapy With or Without Interleukin-2 in Treating Patients With Metastatic Melanoma

Who this might be right for
Stage IV MelanomaRecurrent Melanoma
National Cancer Institute (NCI)
Early research (Phase 1)Ended earlyNCT00005655
What this trial is testing

Combination Therapy of Interleukin-12 and Interleukin-2 to Treat Advanced Cancer

Who this might be right for
Kidney NeoplasmLung NeoplasmSarcoma+1 more
National Cancer Institute (NCI) 39
Testing effectiveness (Phase 2)Study completedNCT00703222
What this trial is testing

A Phase I/II Study Of Immunization With Lymphotactin And Interleukin 2 Gene Modified Neuroblastoma Tumor Cells

Who this might be right for
Neuroblastoma
Baylor College of Medicine 7
Testing effectiveness (Phase 2)Study completedNCT05605665
What this trial is testing

Low-dose Interleukin-2 and Rapamycin on sjögren's Syndrome

Who this might be right for
Sjögren's Syndrome
Peking University People's Hospital 30
Testing effectiveness (Phase 2)Study completedNCT00006244
What this trial is testing

Melphalan, Peripheral Stem Cell Transplantation, and Interleukin-2 Followed by Interferon Alfa in Treating Patients With Advanced Multiple Myeloma

Who this might be right for
Refractory Multiple MyelomaStage I Multiple MyelomaStage II Multiple Myeloma+1 more
Fred Hutchinson Cancer Center 36
Testing effectiveness (Phase 2)UnknownNCT00003181
What this trial is testing

Interleukin-2, Vinblastine, and GM-CSF in Treating Patients With Metastatic Kidney Cancer

Who this might be right for
Kidney Cancer
Hope Cancer Institute, Inc. 35
Large-scale testing (Phase 3)UnknownNCT00002702
What this trial is testing

Surgery and Radiation Therapy With or Without Interleukin-2 in Treating Patients With Cancer of the Mouth or Oropharynx

Who this might be right for
Head and Neck Cancer
European Institute of Oncology 260
Testing effectiveness (Phase 2)Study completedNCT04241601
What this trial is testing

Low-dose Interleukin-2 for the Reduction of Vascular Inflammation in Acute Coronary Syndromes - IVORY

Who this might be right for
Acute Coronary Syndromes
Cambridge University Hospitals NHS Foundation Trust 60
Testing effectiveness (Phase 2)Study completedNCT00002669
What this trial is testing

Combination Chemotherapy, Interferon Alfa, and Interleukin-2 in Treating Patients With Metastatic Melanoma

Who this might be right for
Melanoma (Skin)
European Organisation for Research and Treatment of Cancer - EORTC 90
Load More Results